Lexaria Bioscience Corp.

NASDAQ:LEXX

2.75 (USD) • At close May 22, 2024
Bedrijfsnaam Lexaria Bioscience Corp.
Symbool LEXX
Munteenheid USD
Prijs 2.75
Beurswaarde 35,435,675
Dividendpercentage 0%
52-weken bereik 0.649 - 6.85
Industrie Biotechnology
Sector Healthcare
CEO Mr. Christopher A. Bunka
Website https://www.lexariabioscience.com

An error occurred while fetching data.

Over Lexaria Bioscience Corp.

Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids

Vergelijkbare Aandelen

CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc.

CNSP

0.207 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)